iShares US Aerospace & Defense ETF vs Liquidia Corporation Common Stock — how do they compare? iShares US Aerospace & Defense ETF trades at $204.16 (market cap $11.96B), while Liquidia Corporation Common Stock trades at $33.69 (market cap $2.40B). The key difference: iShares US Aerospace & Defense ETF is far larger — about 5× Liquidia Corporation Common Stock's market cap, and iShares US Aerospace & Defense ETF is more actively traded (750,577 versus 2,857,547). Which is the better fit depends on your goals — on Pluang, investors hold iShares US Aerospace & Defense ETF for 24 Days and Liquidia Corporation Common Stock for 0 Days on average.
| ITA | LQDA | |
|---|---|---|
Market Cap | $11.96B | $2.40B |
Volume | 750,577 | 2,857,547 |
Sector | Sector/Thematic | Health |
52-Week High | $253.22 | $91.03 |
52-Week Low | $198.23 | $22.02 |
Typical Hold Time | 24 Days | 0 Days |
Enterprise Value | — | $2.30B |
Signals from Pluang's Aura AI — not financial advice
ITA trades at $204.00, down 0.99% with bearish technical signals from moving averages. The ETF shows neutral oscillators but faces selling pressure with RSI at oversold levels. Recent corporate actions include a 1:3 stock split scheduled for November 2026 and a $0.25 dividend payment in September 2026. Defense sector momentum remains strong with multiple contract wins and geopolitical tensions driving demand.
The defense sector outlook appears favorable with increased government spending and geopolitical tensions, though ITA faces technical headwinds. Key risks include defense budget volatility and geopolitical resolution. Analyst sentiment remains mixed with the ETF positioned to benefit from ongoing military modernization programs and replenishment of defense inventories.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
iShares U.S. Aerospace & Defense ETF seeks to track U.S. companies in the aerospace and defense sector. Its holdings include manufacturers of commercial and military aircraft, defense systems, and related equipment.
Read more on ITA →Liquidia Corporation is a biopharmaceutical company that develops therapies for rare cardiopulmonary diseases, including YUTREPIA, an inhaled treprostinil powder for pulmonary hypertension built on its PRINT technology.
Read more on LQDA →